# Macerich Co: financial statements, quarterly

MAC · NYSE · CIK 912242 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mac.md) · [Financials](/companies/mac/financials.md) · [Filings](/companies/mac/filings.md) · [Insiders](/companies/mac/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mac/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [218](/filings/0000912242-24-000130.md) | [239 d](/filings/0000912242-26-000016.md) | [209](/filings/0000912242-25-000045.md) | [216](/filings/0000912242-25-000068.md) | [220](/filings/0000912242-25-000076.md) | [274 d](/filings/0000912242-26-000016.md) | [249](/filings/0000912242-26-000024.md) | [250](/filings/0000912242-26-000037.md) | [253](/filings/0000912242-25-000076.md) | [262 d](/filings/0000912242-26-000016.md) | [242](/filings/0000912242-26-000024.md) | [250](/filings/0000912242-26-000037.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.7](/filings/0000912242-24-000130.md) | [(0.7) d](/filings/0000912242-26-000016.md) | [(1.2)](/filings/0000912242-25-000045.md) | [0.3](/filings/0000912242-25-000068.md) | [0.5](/filings/0000912242-25-000076.md) | [(0.9) d](/filings/0000912242-26-000016.md) | [(0.8)](/filings/0000912242-26-000024.md) | [(0.2)](/filings/0000912242-26-000037.md) | [(0.7)](/filings/0000912242-25-000076.md) | [(0.5) d](/filings/0000912242-26-000016.md) | [(2.6)](/filings/0000912242-26-000024.md) | [0.5](/filings/0000912242-26-000037.md) |
| Net income | $m | [(263)](/filings/0000912242-24-000130.md) | [62.2 d](/filings/0000912242-26-000016.md) | [(127)](/filings/0000912242-25-000045.md) | [252](/filings/0000912242-25-000068.md) | [(108)](/filings/0000912242-25-000076.md) | [(211) d](/filings/0000912242-26-000016.md) | [(50.1)](/filings/0000912242-26-000024.md) | [(40.9)](/filings/0000912242-26-000037.md) | [(87.4)](/filings/0000912242-25-000076.md) | [(18.8) d](/filings/0000912242-26-000016.md) | [(36.4)](/filings/0000912242-26-000024.md) | [(27.1)](/filings/0000912242-26-000037.md) |
| Diluted EPS | $ per share | [(1.22)](/filings/0000912242-24-000130.md) | not reported | [(0.59)](/filings/0000912242-25-000045.md) | [1.16](/filings/0000912242-25-000068.md) | [(0.50)](/filings/0000912242-25-000076.md) | not reported | [(0.20)](/filings/0000912242-26-000024.md) | [(0.16)](/filings/0000912242-26-000037.md) | [(0.34)](/filings/0000912242-25-000076.md) | not reported | [(0.14)](/filings/0000912242-26-000024.md) | [(0.10)](/filings/0000912242-26-000037.md) |
| Basic EPS | $ per share | [(1.22)](/filings/0000912242-24-000130.md) | not reported | [(0.59)](/filings/0000912242-25-000045.md) | [1.16](/filings/0000912242-25-000068.md) | [(0.50)](/filings/0000912242-25-000076.md) | not reported | [(0.20)](/filings/0000912242-26-000024.md) | [(0.16)](/filings/0000912242-26-000037.md) | [(0.34)](/filings/0000912242-25-000076.md) | not reported | [(0.14)](/filings/0000912242-26-000024.md) | [(0.10)](/filings/0000912242-26-000037.md) |

- Revenue: us-gaap:Revenues
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [112](/filings/0000912242-24-000130.md) | [94.9](/filings/0000912242-26-000016.md) | [120](/filings/0000912242-25-000045.md) | [70.7](/filings/0000912242-25-000068.md) | [116](/filings/0000912242-25-000076.md) | [89.9](/filings/0000912242-26-000037.md) | [253](/filings/0000912242-26-000024.md) | [131](/filings/0000912242-26-000037.md) | [290](/filings/0000912242-25-000076.md) | [280](/filings/0000912242-26-000037.md) | [182](/filings/0000912242-26-000024.md) | [227](/filings/0000912242-26-000037.md) |
| Total assets | $m | [7,588](/filings/0000912242-23-000026.md) | [7,514](/filings/0000912242-25-000023.md) | [7,363](/filings/0000912242-24-000083.md) | [7,778](/filings/0000912242-24-000125.md) | [7,590](/filings/0000912242-24-000130.md) | [8,567](/filings/0000912242-26-000016.md) | [8,680](/filings/0000912242-25-000045.md) | [8,729](/filings/0000912242-25-000068.md) | [8,424](/filings/0000912242-25-000076.md) | [8,369](/filings/0000912242-26-000037.md) | [8,192](/filings/0000912242-26-000024.md) | [8,524](/filings/0000912242-26-000037.md) |
| Total liabilities | $m | [5,090](/filings/0000912242-23-000026.md) | [4,986](/filings/0000912242-25-000023.md) | [5,002](/filings/0000912242-24-000083.md) | [5,189](/filings/0000912242-24-000125.md) | [5,001](/filings/0000912242-24-000130.md) | [5,725](/filings/0000912242-26-000016.md) | [5,936](/filings/0000912242-25-000045.md) | [6,066](/filings/0000912242-25-000068.md) | [5,842](/filings/0000912242-25-000076.md) | [5,842](/filings/0000912242-26-000037.md) | [5,680](/filings/0000912242-26-000024.md) | [5,616](/filings/0000912242-26-000037.md) |
| Long-term debt | $m | [4,166](/filings/0000912242-23-000026.md) | [4,136](/filings/0000912242-25-000023.md) | [4,099](/filings/0000912242-24-000083.md) | [4,373](/filings/0000912242-24-000125.md) | [4,342](/filings/0000912242-24-000130.md) | [4,895](/filings/0000912242-26-000016.md) | [5,232](/filings/0000912242-25-000045.md) | [5,230](/filings/0000912242-25-000068.md) | [5,077](/filings/0000912242-25-000076.md) | [5,069](/filings/0000912242-26-000037.md) | [4,851](/filings/0000912242-26-000024.md) | [4,848](/filings/0000912242-26-000037.md) |
| Shareholders' equity | $m | [2,432](/filings/0000912242-23-000026.md) | [2,447](/filings/0000912242-25-000023.md) | [2,287](/filings/0000912242-24-000083.md) | [2,505](/filings/0000912242-24-000125.md) | [2,512](/filings/0000912242-24-000130.md) | [2,756](/filings/0000912242-26-000016.md) | [2,664](/filings/0000912242-25-000045.md) | [2,585](/filings/0000912242-25-000068.md) | [2,511](/filings/0000912242-25-000076.md) | [2,449](/filings/0000912242-26-000037.md) | [2,438](/filings/0000912242-26-000024.md) | [2,827](/filings/0000912242-26-000037.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [107 d](/filings/0000912242-24-000130.md) | [49.4 d](/filings/0000912242-26-000016.md) | [61.1](/filings/0000912242-25-000045.md) | [67.4 d](/filings/0000912242-25-000068.md) | [100 d](/filings/0000912242-25-000076.md) | [54.9 d](/filings/0000912242-26-000016.md) | [88.5](/filings/0000912242-26-000024.md) | [70.5 d](/filings/0000912242-26-000037.md) | [112 d](/filings/0000912242-25-000076.md) | [50.2 d](/filings/0000912242-26-000016.md) | [77.4](/filings/0000912242-26-000024.md) | [66.9 d](/filings/0000912242-26-000037.md) |
| Dividends paid | $m | [39.0 d](/filings/0000912242-24-000130.md) | [39.2 d](/filings/0000912242-26-000016.md) | [39.2](/filings/0000912242-25-000045.md) | [41.0 d](/filings/0000912242-25-000068.md) | [39.8 d](/filings/0000912242-25-000076.md) | [41.2 d](/filings/0000912242-26-000016.md) | [50.4](/filings/0000912242-26-000024.md) | [45.7 d](/filings/0000912242-26-000037.md) | [45.9 d](/filings/0000912242-25-000076.md) | [46.2 d](/filings/0000912242-26-000016.md) | [49.0](/filings/0000912242-26-000024.md) | [51.8 d](/filings/0000912242-26-000037.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [215](/filings/0000912242-23-000026.md) | [215](/filings/0000912242-24-000083.md) | [215](/filings/0000912242-24-000125.md) | [216](/filings/0000912242-24-000130.md) | [216](/filings/0000912242-25-000045.md) | [216](/filings/0000912242-25-000068.md) | [218](/filings/0000912242-25-000076.md) | [253](/filings/0000912242-26-000024.md) | [253](/filings/0000912242-26-000037.md) | [254](/filings/0000912242-25-000076.md) | [258](/filings/0000912242-26-000024.md) | [274](/filings/0000912242-26-000037.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 283,559,375 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0000912242-26-000037.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.